Nextage Therapeutics Ltd. Logo

Nextage Therapeutics Ltd.

Develops cannabinoid-based therapeutics using a proprietary drug delivery platform.

NXTG | TA

Overview

Description

Nextage Therapeutics Ltd. is a pharmaceutical company focused on the development of cannabinoid-based therapeutic products. The company utilizes a proprietary drug delivery platform, including a brain-targeting liposome system, to enhance the delivery and efficacy of active pharmaceutical ingredients. Originating from Nextar Chempharma Solutions, a contract development and manufacturing organization (CDMO), Nextage leverages expertise in chemical and product development to create innovative treatments. The company's activities also include providing product development services within the pharmaceutical sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-28 11:29
Suspension of trade due to failure in publishing financial reports-Notification
English 130.4 KB
2025-04-08 19:36
The sector classification of NEXTAGE THERAPEUTICS will be changed, as of April …
Hebrew (modern) 104.0 KB
2025-01-19 13:36
Discontinuation of Market Making
Hebrew (modern) 119.8 KB
2022-02-02 17:02
Opening of Trading On February 3 2022-NEXTAGE W27
Hebrew (modern) 255.8 KB
2022-02-01 15:14
Identifying Details of New Security- NEXTAGE W27
Hebrew (modern) 88.6 KB
2021-02-09 15:18
On Wednesday, Feruary 10 2021, trading will commence in the following security:…
Hebrew (modern) 175.0 KB
2021-01-28 19:11
Rights Offering and Identifying Details for New Securities: NEXTAGE R1, NEXTAGE…
Hebrew (modern) 246.1 KB
2020-08-26 15:24
CHANGES IN COMPANY'S AND SECURITIES NAMES EFFECTIVE OF August 30, 2020
Hebrew (modern) 171.2 KB
2020-08-13 20:02
Further to completion of a big allotment and in light of compliance with TASE's…
Hebrew (modern) 94.0 KB

Automate Your Workflow. Get a real-time feed of all Nextage Therapeutics Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nextage Therapeutics Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nextage Therapeutics Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1000mercis Logo
Marketing technology group for data-driven advertising and CRM solutions.
France
ALMIL
3 E Network Technology Group Ltd Logo
B2B IT solutions provider of software for property, restaurant, and clean energy.
United States of America
MASK
4C Group AB Logo
Provides software and expert services for readiness, training, and crisis management.
Sweden
4C
4GLOBAL PLC Logo
A data, services, and software company for the sports and physical activity sector.
United Kingdom
4GBL
ABEJA,Inc. Logo
An AI technology company that facilitates the digital transformation of businesses.
Japan
5574
Abra Information Technologies Ltd. Logo
Develops, implements, and integrates complex software and hardware solutions.
Israel
ABRA
Accenture plc Logo
A global professional services firm offering strategy, consulting, tech, and operations.
United States of America
ACN
ACCESSO TECHNOLOGY GROUP PLC Logo
Technology provider of software solutions for the leisure and entertainment markets.
United Kingdom
ACSO
ACMOS INC. Logo
An information technology company providing IT solutions and operational support services.
Japan
6888
Addnode Group Logo
Acquires and develops businesses that provide software and digital services.
Sweden
ANOD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.